InvestorsHub Logo

Fmello

12/27/21 11:10 AM

#3119 RE: midastouch017 #3118

If I remember correctly, there were 10 people in the expanded access protocol. Too bad it's not for everyone that participated in the phase 3 trial. That would be a lot of additional data that could have been useful to help push for FDA approval.